Correlation Between JB Chemicals and UTI Asset

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both JB Chemicals and UTI Asset at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining JB Chemicals and UTI Asset into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between JB Chemicals Pharmaceuticals and UTI Asset Management, you can compare the effects of market volatilities on JB Chemicals and UTI Asset and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in JB Chemicals with a short position of UTI Asset. Check out your portfolio center. Please also check ongoing floating volatility patterns of JB Chemicals and UTI Asset.

Diversification Opportunities for JB Chemicals and UTI Asset

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between JBCHEPHARM and UTI is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding JB Chemicals Pharmaceuticals and UTI Asset Management in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UTI Asset Management and JB Chemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on JB Chemicals Pharmaceuticals are associated (or correlated) with UTI Asset. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UTI Asset Management has no effect on the direction of JB Chemicals i.e., JB Chemicals and UTI Asset go up and down completely randomly.

Pair Corralation between JB Chemicals and UTI Asset

Assuming the 90 days trading horizon JB Chemicals Pharmaceuticals is expected to generate 0.52 times more return on investment than UTI Asset. However, JB Chemicals Pharmaceuticals is 1.91 times less risky than UTI Asset. It trades about -0.19 of its potential returns per unit of risk. UTI Asset Management is currently generating about -0.32 per unit of risk. If you would invest  187,035  in JB Chemicals Pharmaceuticals on October 30, 2024 and sell it today you would lose (10,870) from holding JB Chemicals Pharmaceuticals or give up 5.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

JB Chemicals Pharmaceuticals  vs.  UTI Asset Management

 Performance 
       Timeline  
JB Chemicals Pharmac 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days JB Chemicals Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, JB Chemicals is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.
UTI Asset Management 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days UTI Asset Management has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

JB Chemicals and UTI Asset Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with JB Chemicals and UTI Asset

The main advantage of trading using opposite JB Chemicals and UTI Asset positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if JB Chemicals position performs unexpectedly, UTI Asset can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UTI Asset will offset losses from the drop in UTI Asset's long position.
The idea behind JB Chemicals Pharmaceuticals and UTI Asset Management pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance